Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3A | P49840 | 1/20 | 0.31 |
| ▸ | GSK3B | P49841 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Potassium Ion SCHEMBL10908762 | 0.96 | GSK3A (0.31) | GSK3AGSK3B | |
| Benzoic Acid SCHEMBL6660440 | 0.86 | CA2 (0.55) | KDM4EALDH1A1HPGD | |
| SCHEMBL10870360 | 0.79 | GSK3A (0.35) | GSK3AGSK3B | |
| SCHEMBL36449 | 0.77 | GSK3A (0.33) | GSK3AGSK3B | |
| SCHEMBL3205528 | 0.68 | ALDH1A1 (0.32) | ALDH1A1 | |
| SCHEMBL1682242 | 0.68 | CA12 (0.43) | KDM4EALDH1A1HPGD | |
| SCHEMBL10705581 | 0.67 | — | — | |
| SCHEMBL47924 | 0.67 | CA12 (0.42) | KDM4EALDH1A1HPGD | |
| Silver SCHEMBL38664429 | 0.64 | — | — | |
| Zinc Ion SCHEMBL10613130 | 0.62 | CA2 (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119212567-A | Method for preparing cereal tempeh, cereal tempeh prepared by said method, sauce comprising prepared cereal tempeh, and preparation method thereof | CJ第一制糖株式会社 | 2024-12-27 | — | — | CN | disclosed |
| CN-119156141-A | Preparation method of tempeh, tempeh prepared from tempeh, sauce containing tempeh and preparation method of sauce | CJ第一制糖株式会社 | 2024-12-17 | — | — | CN | disclosed |
| US-20160090600-A1 | COMPOSITION FOR EXTERNAL APPLICATION COMPRISING TRANSCRIPTION FACTOR DECOY AS ACTIVE INGREDIENT | ANGESMG, INC. (JP) | 2016-03-31 | — | — | US | disclosed |
| EP-2266626-B1 | COMPOSITION FOR EXTERNAL APPLICATION COMPRISING TRANSCRIPTION FACTOR DECOY AS ACTIVE INGREDIENT | ANGESMG INC (JP) | 2014-06-18 | — | — | EP | disclosed |
| US-8114906-B2 | Essential fatty acids in the treatment and/or inhibition of depression in patients with coronary heart or artery disease | ABBOTT PRODUCTS GMBH (DE) | 2012-02-14 | — | — | US | disclosed |
| US-20110092438-A1 | Composition for external application comprising transcription factor decoy as active ingredient | ANGESMG, INC. | 2011-04-21 | — | — | US | disclosed |
| EP-2266626-A1 | COMPOSITION FOR EXTERNAL APPLICATION COMPRISING TRANSCRIPTION FACTOR DECOY AS ACTIVE INGREDIENT | AnGes MG, Inc. (JP) | 2010-12-29 | — | — | EP | disclosed |
| US-20090304607-A1 | Antibacterial Flavor and Fragance Composition and Halitosis-Inhibition Flavor and Fragrance Composition and Oral Care Composition Containing the Same | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2009-12-10 | — | — | US | disclosed |
| US-7619002-B2 | Use of polyunsaturated fatty acids for the primary prevention of major cardiovascular events | Pro Aparts Investimentos E Consultoria LDA. AV. Arriaga (PT) | 2009-11-17 | — | — | US | disclosed |
| US-7553870-B2 | Use of polyunsaturated fatty acid for the primary prevention of major cardiovascular events | PRO APARTS INVESTIMENTOS E CONSULTORIA LDA (PT) | 2009-06-30 | — | — | US | disclosed |
| EP-1152755-B1 | ESSENTIAL FATTY ACIDS IN THE PREVENTION OF CARDIOVASCULAR EVENTS | PHARMACIA & UPJOHN SPA (IT) | 2002-04-17 | — | — | EP | disclosed |
| EP-1152755-A1 | ESSENTIAL FATTY ACIDS IN THE PREVENTION OF CARDIOVASCULAR EVENTS | PHARMACIA & UPJOHN S.p.A. (IT) | 2001-11-14 | — | — | EP | disclosed |
| JP-2001157577-A | METHOD FOR PRODUCING DRINKING WATER CONTAINING LOW NUTRITIONAL MICROORGANISM AND MEDIUM FOR DETECTING LOW NUTRITIONAL MICROORGANISM | KANSAI SOGO KANKYO CENTER:KK | 2001-06-12 | — | — | JP | disclosed |
| WO-2000048592-A1 | ESSENTIAL FATTY ACIDS IN THE PREVENTION OF CARDIOVASCULAR EVENTS | PHARMACIA & UPJOHN S.P.A. (IT) | 2000-08-24 | — | — | WO | disclosed |
| US-5780472-A | ANTITUMOR AGENTS | SAMJIN PHARMACEUTICAZL CO., LTD. (KR) | 1998-07-14 | — | — | US | disclosed |
| US-5719155-A | CARDIOVASCULAR DISORDERS | JAPAN TOBACCO INC. (JP) | 1998-02-17 | — | — | US | disclosed |
| EP-0749425-A1 | NEW PIPERAZINE DERIVATIVES AND METHODS FOR THE PREPARATION THEREOF AND COMPOSITIONS CONTAINING THE SAME | SAMJIN PHARM. CO., LTD. (KR) | 1996-12-27 | — | — | EP | disclosed |
| EP-0455830-B1 | MEDICINE CONTAINING THIAZINE DIOXIDE DERIVATIVE | NIPPON HYPOX LAB INC (JP) | 1996-06-26 | — | — | EP | disclosed |
| EP-0677519-A1 | CHROMAN DERIVATIVE AND MEDICINAL USE THEREOF | Japan Tobacco Inc. (JP) | 1995-10-18 | — | — | EP | disclosed |
| EP-0455830-A1 | MEDICINE CONTAINING THIAZINE DIOXIDE DERIVATIVE | NIPPON HYPOX LABORATORIES INCORPORATED (JP) | 1991-11-13 | — | — | EP | disclosed |